MabCure, Inc. (MBCI) es una empresa que cotiza en bolsa en el Energía sector, operando dentro de la Solar industria. La empresa tiene su sede en White Plains, NY, United States. El CEO actual es Jehu Thomas Degerold Hand.
MBCI tiene fecha de IPO 2007-12-05, 3 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $36.61K.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
